House Energy And Commerce Lists Infant Formula Crisis First In Stating FDA Oversight Priorities
Infant formula supply shortage affecting US since early 2022 is first among multiple FDA concerns Energy and Commerce GOP leadership stated in plan submitted to Oversight and Rules Committee, as required in a standing House rule.
You may also be interested in...
On same day agency published strategy for ensuring formula supply, House Oversight Committee subcommittee members made clear they’re not convinced FDA could prevent repeat of 2022 shortage. Recently resigned FDA food policy chief also has doubts.
“Something needed to be done” to improve FDA’s regulation of human foods supply, says Commissioner Califf says. “Dietary supplements is a whole different kettle of fish that we can discuss at a later time.”
Following reviews prompted largely by formula supply crisis, FDA will move Center for Food Safety and Applied Nutrition and commissioner’s Office of Food Programs and Response to Human Foods Program headed by deputy commissioner. Office of Regulatory Affairs' structure also changing “to support the FDA organization as a whole,” says Commissioner Califf.